If you have been reading about Reverse-phase HPLC and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-09-15. Numbers and descriptions here follow the published literature rather than marketing material.
Reverse-phase high-performance liquid chromatography is the standard technique for assessing purity and concentration, because the peptide's hydrophobicity allows clean separation from related impurities. Mass spectrometry confirms molecular identity and detects sequence errors or truncations. Amino acid analysis and peptide mapping supply additional structural confirmation when required. Chromatographic purity values reported on certificates of analysis describe the proportion of the main peak and do not by themselves establish biological activity.
Like most short peptides, thymosin alpha-1 is susceptible to hydrolysis under strongly acidic or basic conditions and to oxidation when exposed to air over long periods. The acetylated amino terminus blocks one common degradation route, which contributes to the molecule's relative robustness in solution. Lyophilized material generally retains potency for extended periods when kept cold and dry. Once reconstituted, aqueous solutions are less stable and are typically used within a defined window rather than held indefinitely at ambient temperature.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
| Property | Value | Notes |
|---|---|---|
| Primary structure | 28 amino acid residues | N-terminally acetylated |
| Net charge at neutral pH | Negative | Acidic peptide |
| Typical purity assay | Reverse-phase HPLC | UV detection near 214 nm |
| Identity confirmation | Mass spectrometry | Matches expected molecular mass |
| Reconstitution solvent | Sterile water or saline | Follow supplier instructions |
Lyophilized material is generally held at reduced temperature to slow degradation, and storage at minus twenty degrees Celsius or lower is common practice for long-term retention. Short-term working portions are often kept between two and eight degrees Celsius. Once dissolved, the peptide is less stable than the dry powder, and repeated freeze-thaw cycles are associated with loss of material and with aggregate formation. Vials are usually allowed to reach room temperature before opening so that condensation does not introduce moisture, and solutions are protected from light where practical.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography, which separates the peptide from closely related impurities and from truncated or oxidized variants. Mass spectrometry supplies the molecular mass and confirms the expected sequence length, while amino acid analysis can be used to check composition. Because the molecule has no chromophore beyond the peptide backbone, ultraviolet detection is typically performed at a low wavelength, where baseline interference from solvents and buffers is a practical concern. Water content and counter-ion content are often reported alongside purity.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
The activity of this peptide is generally described as immunomodulatory rather than directly antimicrobial. Experimental work links it to signaling through certain Toll-like receptors on dendritic cells and to downstream maturation of antigen-presenting cells. Reported effects include expansion of T cell subsets, shifts in cytokine profiles, and increased natural killer cell activity. These observations come largely from cell culture and animal models, and the precise receptor-level events in humans remain incompletely characterized.
The compound has been investigated as an adjunct in chronic viral hepatitis and as a vaccine adjuvant, with results that vary by study design and population. Regulators in some countries have approved a synthetic form for specific indications, while other agencies have not. Whether the peptide produces consistent clinical benefit across diverse patient groups is still an open question, and many trials have been small. Its status is therefore best described as investigational in many contexts and established only narrowly.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
Chief of the Defence Force – overall senior command officer Chief of the Army Chief of the Air Force Chief of the Navy Chief of the Medical Service (Surgeon General) Staff Divisions under the Chief of Defence Staff included:
In adults, the primary metabolic pathway for paracetamol is glucuronidation. This yields a relatively non-toxic metabolite, which is excreted into bile and passed out of the body. A small amount of the drug is metabolized via the cytochrome P-450 pathway (to be specific, CYP3A4 and CYP2E1) into NAPQI, which is extremely toxic to liver tissue, as well as being a strong biochemical oxidizer. In an average adult, only a small amount (approximately 10% of a therapeutic paracetamol dose) of NAPQI is produced, which is inactivated by conjugation with glutathione (GSH). The amount of NAPQI produced differs in certain populations. The minimum dosage at which paracetamol causes toxicity usually is 7.5 to 10g in the average person. The lethal dose is usually between 10 g and 15 g. Concurrent alcohol intake lowers these thresholds significantly. Chronic alcoholics may be more susceptible to adverse effects due to reduced glutathione levels. Other populations may experience effects at lower or higher dosages depending on differences in P-450 enzyme activity and other factors which affect the amount of NAPQI produced. In general, however, the primary concern is accidental or intentional paracetamol overdose. When a toxic dose of paracetamol is ingested, the normal glucuronide pathway is saturated and large amounts of NAPQI are produced. Liver reserves of glutathione are depleted by conjugation with this excess NAPQI.
==== MeSH E05.318.308 – data collection ==== MeSH E05.318.308.225 – geriatric assessment MeSH E05.318.308.250 – health surveys MeSH E05.318.308.250.149 – behavioral risk factor surveillance system MeSH E05.318.308.250.300 – dental health surveys MeSH E05.318.308.250.300.300 – dental plaque index MeSH E05.318.308.250.300.350 – dmf index MeSH E05.318.308.250.300.675 – oral hygiene index MeSH E05.318.308.250.300.725 – periodontal index MeSH E05.318.308.250.475 – health status indicators MeSH E05.318.308.250.475.365 – apache MeSH E05.318.308.250.475.547 – severity of illness index MeSH E05.318.308.250.475.547.500 – karnofsky performance status MeSH E05.318.308.250.475.730 – sickness impact profile MeSH E05.318.308.250.580 – mass screening MeSH E05.318.308.250.580.174 – anonymous testing MeSH E05.318.308.250.580.350 – genetic screening MeSH E05.318.308.250.580.510 – mass chest x-ray MeSH E05.318.308.250.580.560 – multiphasic screening MeSH E05.318.308.250.580.580 – neonatal screening MeSH E05.318.308.250.580.925 – vision screening MeSH E05.318.308.250.600 – nutrition surveys MeSH E05.318.308.250.600.350 – diet surveys MeSH E05.318.308.250.700 – population surveillance MeSH E05.318.308.250.700.650 – sentinel surveillance MeSH E05.318.308.335 – health care surveys MeSH E05.318.308.420 – interviews MeSH E05.318.308.420.200 – focus groups MeSH E05.318.308.502 – narration MeSH E05.318.308.585 – nutrition assessment MeSH E05.318.308.585.550 – nutrition surveys MeSH E05.318.308.585.550.350 – diet surveys MeSH E05.318.308.750 – questionnaires MeSH E05.318.308.940 – records MeSH E05.318.308.940.250 – birth certificates MeSH E05.318.308.940.350 – death certificates MeSH E05.318.308.940.375 – dental records MeSH E05.318.308.940.425 – hospital records MeSH E05.318.308.940.968 – medical records MeSH E05.318.308.940.968.500 – medical record linkage MeSH E05.318.308.940.968.625 – medical records systems, computerized MeSH E05.318.308.940.968.750 – medical records, problem-oriented MeSH E05.318.308.940.968.875 – trauma severity indices MeSH E05.318.308.940.968.875.125 – abbreviated injury scale MeSH E05.318.308.940.968.875.250 – glasgow coma scale MeSH E05.318.308.940.968.875.260 – glasgow outcome scale MeSH E05.318.308.940.968.875.500 – injury severity score MeSH E05.318.308.940.984 – nursing records MeSH E05.318.308.970 – registries MeSH E05.318.308.970.725 – seer program MeSH E05.318.308.985 – vital statistics MeSH E05.318.308.985.450 – life expectancy MeSH E05.318.308.985.475 – life tables MeSH E05.318.308.985.525 – morbidity MeSH E05.318.308.985.525.080 – basic reproduction number MeSH E05.318.308.985.525.375 – incidence MeSH E05.318.308.985.525.750 – prevalence MeSH E05.318.308.985.550 – mortality MeSH E05.318.308.985.550.250 – cause of death MeSH E05.318.308.985.550.287 – child mortality MeSH E05.318.308.985.550.325 – fatal outcome MeSH E05.318.308.985.550.362 – fetal mortality MeSH E05.318.308.985.550.400 – hospital mortality MeSH E05.318.308.985.550.475 – infant mortality MeSH E05.318.308.985.550.500 – maternal mortality MeSH E05.318.308.985.550.900 – survival rate MeSH E05.318.308.985.775 – pregnancy rate MeSH E05.318.308.985.775.500 – birth rate
== Dosing considerations == The recommended intravenous dosage in adults is 500 mg every 6 hours or 1000 mg every 12 hours, with modification to achieve a therapeutic range as needed. The recommended oral dosage in the treatment of antibiotic-induced pseudomembranous enterocolitis is 125 to 500 mg every 6 hours for 7 to 10 days. Dose optimization and target attainment of vancomycin in children involves adjusting the dosage to maximize effectiveness while minimizing the risk of adverse effects, specifically acute kidney injury. Dose optimization is achieved by therapeutic drug monitoring (TDM), which allows measurement of vancomycin levels in the blood. TDM using area under the curve (AUC)-guided dosing, preferably with Bayesian forecasting, is recommended to ensure that the AUC0-24h/minimal inhibitory concentration (MIC) ratio is maintained above a certain threshold (400–600) associated with optimal efficacy.
Sources: en.wikipedia.org
== Medical uses == The main indication for SSRIs is major depressive disorder; however, they are frequently prescribed for anxiety disorders, such as social anxiety disorder, generalized anxiety disorder, panic disorder, obsessive–compulsive disorder, eating disorders, chronic pain, and, in some cases, for post-traumatic stress disorder. They are also frequently used to treat depersonalization disorder, although with varying results.
=== China === As of March 2025, the government is estimated to have 401 million barrels stored in above-ground facilities and 668 million barrels in above-ground commercial storage. By December 2025, United States Energy Information Administration estimated Chinese held around 1.4 billion barrels of crude oil in reserve from both government-held and state-owned national oil companies (NOC) inventories, which are both part of the strategic reserves. Outside of the official strategic reserves, Chinese corporate and commercial refineries also have several hundred million barrels of crude oil. China hiked prices serveal times during the war, but due to queue forming in the gas stations in multiple Chinese cities, the Chinese government reduced its planned fuel price hikes. China's large strategic reserve helped the country insulate itself significantly from the 2026 Iran war and ensuing global fuel crisis. By late June 2026, China's strategic petroleum reserve (SPR) remained nearly unchanged after the Iran war. To ensure domestic supplies without using strategic reserve, China halted its supplies of refined oil products to other countries. China is a major oil refiner and exporter of petroleum products. On 5 March, major Chinese refiners, including China Petroleum & Chemical (Sinopec) and Rongsheng Petrochemical Co Ltd, were ordered by the government to stop accepting new fuel export contracts. Jet fuel refuelling for international flights and supplies to Hong Kong and Macau are exempt from this guidance.
=== Comments on homosexuality === During a performance in Nashville, Tennessee, on June 3, 2011, Morgan made remarks about homosexuals, reportedly stating that if his son were gay, his son better speak to him like a man or he would "pull out a knife and stab him." Morgan apologized, saying that he had "gone too far." In response, head of NBC Entertainment Bob Greenblatt and Morgan's coworker on 30 Rock, Tina Fey, stated they did not condone the comments made by Morgan, and were happy to see him make a sincere apology.
Sources: en.wikipedia.org
The lyophilized solid is normally held at 2 to 8 °C in a sealed, light-protected container. Dry storage limits both hydrolysis and microbial growth. Material kept this way remains stable for the shelf life stated by the supplier.
Reverse-phase HPLC separates the peptide from related impurities and yields a purity estimate. Mass spectrometry confirms the expected molecular mass and flags sequence errors. The two techniques are commonly reported together on a certificate of analysis.
Short exposure during handling is not considered a major problem for the dry powder. Prolonged storage at ambient temperature, especially of reconstituted solutions, raises the risk of degradation. Cold storage remains the standard practice for longer periods.
It corresponds to a fragment of the larger protein prothymosin alpha, which is present in many tissues. The isolated 28-amino-acid peptide was originally obtained from thymus preparations, and the pharmaceutical product is synthesized rather than extracted. The term therefore describes both a natural fragment and a manufactured drug substance.